Month: November 2022

Genthner, Barbara R. Sharak published the artcileReduction of 3-chlorobenzoate, 3-bromobenzoate, and benzoate to corresponding alcohols by Desulfomicrobium escambiense, isolated from a 3-chlorobenzoate-dechlorinating coculture, Product Details of C8H7ClO4, the main research area is Desulfomicrobium chlorobenzoate bromobenzoate benzoate reduction.

An anaerobic bacterial coculture which dechlorinated 3-chlorobenzoate (3CB) to benzoate was obtained by single-colony isolation from an anaerobic bacterial consortium which completely degraded 3CB in defined medium. Of 29 addnl. halogenated aromatic compounds tested, the coculture removed the meta halogen from 2,3- and 2,5-dichlorobenzoate, 3-bromobenzoate (3BB), 5-chlorovanillate (5CV), and 3-chloro-4-hydroxybenzoate. Dechlorinating activity in the coculture required the presence of pyruvate. 5CV was also O-demethoxylated. The coculture contained two cell types: a short, straight gram-neg. rod and a long, thin, curved gram-pos. rod. The short rod, Desulfomicrobium escambiense, was recently isolated and identified as a new sulfate-reducing bacterial species (B. R. Sharak Genthner, S. D. Friedman, and R. Devereux, Int. J. Syst. Bacteriol. 47:889-892, 1997; B. R. Sharak Genthner, G. Mundfrom, and R. Devereux, Arch. Microbiol. 161:215-219, 1994). D. escambiense did not dehalogenate any of the compounds dehalogenated by the coculture, nor did it O-demethoxylate 5CV or vanillate. However, D. escambiense reduced 3CB, 3BB, and benzoate to their resp. benzyl alcs. Reduction to alcs. required the presence of pyruvate, which was transformed to acetate, lactate, and succinate in the presence or absence of 3CB, 3BB, or benzoate. Alc. formation did not occur in pyruvate-sulfate medium. Under these conditions, sulfate was preferentially reduced. Other electron donors that supported the growth of D. escambiense during sulfate reduction did not support benzoate reduction to benzyl alc.

Applied and Environmental Microbiology published new progress about Desulfomicrobium escambiense. 62936-23-6 belongs to class chlorides-buliding-blocks, name is 3-Chloro-4-hydroxy-5-methoxybenzoic acid, and the molecular formula is C8H7ClO4, Product Details of C8H7ClO4.

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Toledo-Sherman, Leticia M. published the artcileDevelopment of a Series of Aryl Pyrimidine Kynurenine Monooxygenase Inhibitors as Potential Therapeutic Agents for the Treatment of Huntington’s Disease, Computed Properties of 480438-56-0, the main research area is arylpyrimidine kynurenine monooxygenase inhibitor preparation SAR Huntingtons disease.

We report on the development of a series of pyrimidine carboxylic acids that are potent and selective inhibitors of kynurenine monooxygenase and competitive for kynurenine. We describe the SAR for this novel series and report on their inhibition of KMO activity in biochem. and cellular assays and their selectivity against other kynurenine pathway enzymes. We describe the optimization process that led to the identification of a program lead compound with a suitable ADME/PK profile for therapeutic development. We demonstrate that systemic inhibition of KMO in vivo with this lead compound provides pharmacodynamic evidence for modulation of kynurenine pathway metabolites both in the periphery and in the central nervous system.

Journal of Medicinal Chemistry published new progress about Central nervous system agents. 480438-56-0 belongs to class chlorides-buliding-blocks, name is 3-Chloro-4-isopropoxyphenylboronic acid, and the molecular formula is C9H12BClO3, Computed Properties of 480438-56-0.

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Wagner, Rolf published the artcileHighlights of the Structure-Activity Relationships of Benzimidazole Linked Pyrrolidines Leading to the Discovery of the Hepatitis C Virus NS5A Inhibitor Pibrentasvir (ABT-530), Safety of 4-Chloro-2-fluoro-5-nitrobenzoic acid, the main research area is HCV antiviral NS5A inhibition Pibrentasvir analog; benzimidazole linked pyrrolidine Pibrentasvir analog preparation antiviral HCV pharmacokinetics.

Curative interferon and ribavirin sparing treatments for hepatitis C virus (HCV)-infected patients require a combination of mechanistically orthogonal direct acting antivirals. A shared component of these treatments is usually an HCV NS5A inhibitor. First generation FDA approved treatments, including the component NS5A inhibitors, do not exhibit equivalent efficacy against HCV virus genotypes 1-6. In particular, these first generation NS5A inhibitors tend to select for viral drug resistance. Ombitasvir is a first generation HCV NS5A inhibitor included as a key component of Viekira Pak for the treatment of patients with HCV genotype 1 infection. Since the launch of next generation HCV treatments, functional cure for genotype 1-6 HCV infections has been achieved, as well as shortened treatment duration across a wider spectrum of genotypes. In this paper, we show how we have modified the anchor, linker, and end-cap architecture of our NS5A inhibitor design template to discover a next generation NS5A inhibitor pibrentasvir (ABT-530), which exhibits potent inhibition of the replication of wild-type genotype 1-6 HCV replicons, as well as improved activity against replicon variants demonstrating resistance against first generation NS5A inhibitors.

Journal of Medicinal Chemistry published new progress about Anti-hepatitis C virus agents. 35112-05-1 belongs to class chlorides-buliding-blocks, name is 4-Chloro-2-fluoro-5-nitrobenzoic acid, and the molecular formula is C7H3ClFNO4, Safety of 4-Chloro-2-fluoro-5-nitrobenzoic acid.

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Kurata, Haruto published the artcileDiscovery of a 1-Methyl-3,4-dihydronaphthalene-Based Sphingosine-1-Phosphate (S1P) Receptor Agonist Ceralifimod (ONO-4641). A S1P1 and S1P5 Selective Agonist for the Treatment of Autoimmune Diseases, COA of Formula: C9H9ClO2, the main research area is sphingosinephosphate receptor agonist ceralifimod immunomodulator autoimmune disease.

The discovery of 1-({6-[(2-methoxy-4-propylbenzyl)oxy]-1-methyl-3,4-dihydronaphthalen-2-yl}methyl)azetidine3-carboxylic acid (I) (13n, ceralifimod, ONO-4641), a sphingosine-1-phosphate (S1P) receptor agonist selective for S1P1 and S1P5, is described. While it has been revealed that the modulation of the S1P1 receptor is an effective way to treat autoimmune diseases such as relapsing-remitting multiple sclerosis (RRMS), it was also reported that activation of the S1P3 receptor is implicated in some undesirable effects. The authors carried out a structure-activity relationship (SAR) study of hit compound 6 with an amino acid moiety in the hydrophilic head region. Following identification of a lead compound with a dihydronaphthalene central core by inducing conformational constraint, optimization of the lipophilic tail region led to the discovery of I as a clin. candidate that exhibited >30 000-fold selectivity for S1P1 over S1P3 and was potent in a peripheral lymphocyte lowering (PLL) test in mice (ED50 = 0.029 mg/kg, 24 h after oral dosing).

Journal of Medicinal Chemistry published new progress about Anti-multiple sclerosis agents. 99585-12-3 belongs to class chlorides-buliding-blocks, name is Methyl 4-chloro-2-methylbenzoate, and the molecular formula is C9H9ClO2, COA of Formula: C9H9ClO2.

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Speri, Enrico published the artcileCinnamonitrile Adjuvants Restore Susceptibility to β-Lactams against Methicillin-Resistant Staphylococcus aureus, Synthetic Route of 61343-99-5, the main research area is preparation cinnamonitrile adjuvant beta lactam MRSA infection.

β-Lactams are used routinely to treat Staphylococcus aureus infections. However, the emergence of methicillin-resistant S. aureus (MRSA) renders them clin. precarious. We describe a class of cinnamonitrile adjuvants that restore the activity of oxacillin (a penicillin member of the β-lactams) against MRSA. The lead adjuvants were tested against six important strains of MRSA, one vancomycin-intermediate S. aureus (VISA) strain, and one linezolid-resistant S. aureus strain. Five compounds out of 84 total compounds showed broad potentiation. At 8 μM (E)-3-(5-(3,4-dichlorobenzyl)-2-(trifluoromethoxy)phenyl)-2-(methylsulfonyl)acrylonitrile (26) potentiated oxacillin with a >4000-fold reduction of its MIC (from 256 to 0.06 mg·L-1). This class of adjuvants holds promise for reversal of the resistance phenotype of MRSA.

ACS Medicinal Chemistry Letters published new progress about Antibacterial agent resistance. 61343-99-5 belongs to class chlorides-buliding-blocks, name is 4-(4-Chlorophenoxy)benzaldehyde, and the molecular formula is C13H9ClO2, Synthetic Route of 61343-99-5.

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Xu, Rui published the artcileDiscovery of spirocyclic sulfonamides as potent Akt inhibitors with exquisite selectivity against PKA, HPLC of Formula: 7079-48-3, the main research area is spirocyclic sulfonamide preparation Akt inhibitor SAR.

We describe the design and synthesis of novel bicyclic spiro sulfonamides, e.g. I, as potent Akt inhibitors. Through structure-based rational design, we have successfully improved PKA selectivity of previously disclosed spirochromanes. Representative compounds showed favorable Akt potency while exhibiting up to 1000-fold selectivity against PKA.

Bioorganic & Medicinal Chemistry Letters published new progress about Structure-activity relationship. 7079-48-3 belongs to class chlorides-buliding-blocks, name is 4-Fluoro-2-methylbenzene-1-sulfonyl chloride, and the molecular formula is C7H6ClFO2S, HPLC of Formula: 7079-48-3.

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Fuller, Ray W. published the artcileNorepinephrine N-methyltransferase inhibition by benzamidines, phenylacetamidines, benzylguanidines, and phenylethylguanidines, HPLC of Formula: 50292-25-6, the main research area is norepinephrine methyltransferase inhibitor amidine; guanidine aryl methyltransferase inhibitor.

Mono- and dichloro derivatives of 21 title compounds and 18 benzylamines, α-methylbenzylamines, and amphetamines were studied as inhibitors of norepinephrine N-methyltransferase (EC 2.1.1.28) [9037-68-7]. The 2 most effective inhibitors in vitro were 2,3-dichlorobenzamidine-HCl (I-HCl) [55154-87-5] and 3,4-dichlorophenylacetamidine (II) [55154-91-1] with pI50 values of 5.55 and 5.36, resp. I and II are reversible inhibitors and competitive with norepinephrine in vitro, but are not effective in blocking enzyme activity in vivo in rats.

Journal of Medicinal Chemistry published new progress about Structure-activity relationship. 50292-25-6 belongs to class chlorides-buliding-blocks, name is 3,4-Dichlorobenzene-1-carboximidamide hydrochloride, and the molecular formula is C7H7Cl3N2, HPLC of Formula: 50292-25-6.

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Gu, Jiali published the artcileRational design of esterase BioH with enhanced enantioselectivity towards methyl (S)-o-chloromandelate, COA of Formula: C9H9ClO3, the main research area is rational design esterase BioH enantioselectivity methyl chloromandelate.

Me (R)-o-chloromandelate (R-CMM) is an intermediate for the platelet aggregation inhibitor clopidogrel. Its preparation through enzymic resolution of the corresponding ester has been hindered by the lack of an enzyme with satisfying enantioselectivity and activity. In the present work, we aimed to improve the enzymic enantioselectivity towards Me (S)-o-chloromandelate (S-CMM) by rational design, using esterase BioH as a model enzyme. Based on the differences in the binding mode of S- and R-enantiomers at the active cavity of the enzyme, the steric and electronic interactions between the key amino acids of BioH and the enantiomers were finely tuned. The enantioselectivity of esterase BioH towards S-CMM was improved from 3.3 (the wild type) to 73.4 (L123V/L181A/L207F). Synergistic interaction was observed between point mutations, and insight into the source of enzymic enantioselectivity was gained by mol. dynamics simulations. The results can provide a reference for the enzyme design of other enzymes towards S-CMM for the enhancement of enantioselectivity.

Applied Microbiology and Biotechnology published new progress about Enzyme functional sites, active. 32345-60-1 belongs to class chlorides-buliding-blocks, name is (S)-Methyl 2-(2-chlorophenyl)-2-hydroxyacetate, and the molecular formula is C9H9ClO3, COA of Formula: C9H9ClO3.

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Laha, Joydev K. published the artcileScope of Successive C-H Functionalizations of the Methyl Group in 3-Picolines: Intramolecular Carbonylation of Arenes to the Metal-Free Synthesis of 4-Azafluorenones, HPLC of Formula: 480438-56-0, the main research area is picoline aryl oxidant intramol carbonylation; azafluorenone preparation.

A transition-metal-free, t-BuOOH mediated intramol. carbonylation of arenes in 2-aryl-3-picolines via oxidative C-H functionalizations of the Me group has been developed, providing an expedient synthesis of 4-azafluorenones I [R = 7-MeO, 7-OCF3, 6,7-Cl2, 6-Cl-7-OPr-i, 7,8-(OMe)2, etc] . Distinct from the current literature wherein methylarenes have been used as acylating agents, 2-aryl-3-picolines in this study are transformed into aldehydes, which give 4-azafluorenones upon rapid intramol. acylation. The study demonstrates the first example of intramol. carbonylation of arenes utilizing a Me group as latent carbonyl functionality.

Organic Letters published new progress about C-H bond activation (oxidative). 480438-56-0 belongs to class chlorides-buliding-blocks, name is 3-Chloro-4-isopropoxyphenylboronic acid, and the molecular formula is C9H12BClO3, HPLC of Formula: 480438-56-0.

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Chen, Peng-Fei published the artcileBronsted Acid Catalyzed Dearomatization by Intramolecular Hydroalkoxylation/Claisen Rearrangement: Diastereo- and Enantioselective Synthesis of Spirolactams, Related Products of chlorides-buliding-blocks, the main research area is spirolactam enantioselective diastereoselective preparation atom economy kinetic resolution; ynamide dearomatization intramol hydroalkoxylation Claisen rearrangement Bronsted acid catalyst; Brønsted acids; alkynes; cyclizations; heterocycles; kinetic resolution.

A novel Bronsted acid catalyzed intramol. hydroalkoxylation/Claisen rearrangement, allowing practical and atom-economic synthesis of a range of valuable spirolactams such as I [R1 = Ph, 4-MeC6H4, 4-F3CC6H4, etc.; R2 = Ph, 2-BrC6H4, 4-MeOC6H4, etc.; R3 = H, 8-F, 7-MeO, etc.; R4 = Ts, SO2Ph, Bs, etc.] from readily available ynamides in generally good to excellent yields with excellent diastereoselectivities and broad substrate scope was described. Importantly, an unexpected dearomatization of nonactivated arenes and heteroaromatic compounds was involved in this tandem sequence. Moreover, an asym. version of this tandem cyclization was also achieved by efficient kinetic resolution by chiral phosphoric acid catalysis. In addition, [3,3]-rearrangement was shown to be kinetically preferred over related [1,3]-rearrangement by theor. calculations

Angewandte Chemie, International Edition published new progress about [3,3]-Sigmatropic rearrangement. 99585-12-3 belongs to class chlorides-buliding-blocks, name is Methyl 4-chloro-2-methylbenzoate, and the molecular formula is C9H9ClO2, Related Products of chlorides-buliding-blocks.

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics